CD26 dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells

被引:19
|
作者
IwakiEgawa, S
Watanabe, Y
Fujimoto, Y
机构
[1] Department of Clinical Biochemistry, Hokkaido Inst. of Pharmaceutical S., Otaru
[2] Department of Clinical Biochemistry, Hokkaido Inst. of Pharmaceutical S., Otaru, Hokkaido 047-02
关键词
D O I
10.1006/cimm.1997.1123
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this paper, we describe further characterization of the membrane-associated molecule CD26/dipeptidyl peptidase IV (DPP IV), which is said to be adenosine deaminase-binding protein (ADA-bp) in humans, to clarify its association with ADA in rat immune cells. For this purpose, we used three types of rats: DPP IV+ rats; DPP IV- rats, which lack enzyme activity and immunological reactivity of DPP IV; and ADA(-) rats, which have reduced ADA activity due to continuous peritoneal injection of 2'-DCF, a potent inhibitor of ADA. ADA existed in the cells of DPP IV+ and DPP IV- rats, but it did not exist on the cell surface in either rat. ADA- rats showed a decrease in ADA activity and in the number of immune cells, but no effect on DPP IV was observed. These data suggest that in rats, in contrast to humans, DPP IV does not exist as ADA-bp. (C) 1997 Academic Press.
引用
收藏
页码:180 / 186
页数:7
相关论文
共 50 条
  • [31] STRUCTURE OF THE MOUSE DIPEPTIDYL PEPTIDASE-IV (CD26) GENE
    BERNARD, AM
    MATTEI, MG
    PIERRES, M
    MARGUET, D
    BIOCHEMISTRY, 1994, 33 (50) : 15204 - 15214
  • [32] Urine adenosine deaminase binding protein (CD26) as a marker for acute illness
    Silverman, R
    Bessette, J
    Lentrichia, B
    CLINICAL CHEMISTRY, 1996, 42 (06) : 633 - 633
  • [33] Dipeptidyl peptidase IV (DPP IV, CD26) in patients with mental eating disorders
    Hildebrandt, M
    Rose, M
    Mayr, C
    Arck, P
    Schüler, C
    Reutter, W
    Salama, A
    Klapp, BF
    CELLULAR PEPTIDASES IN IMMUNE FUNCTIONS AND DISEASES 2, 2000, 477 : 197 - 204
  • [34] Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease
    Hildebrandt, M
    Rose, N
    Rüter, J
    Salama, A
    Mönnikes, H
    Klapp, BF
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (10) : 1067 - 1072
  • [35] DIPEPTIDYL-PEPTIDASE IV (DPP IV/CD26) AND INFLAMMATORY BOWEL DISEASE
    Pucar, Lara Baticic
    Detel, Dijana
    Varljen, Jadranka
    ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY, 2012, 63 (01): : 75 - 100
  • [36] Inhibition of dipeptidyl peptidase IV (CD26) by peptide boronic acid dipeptides
    Pargellis, CA
    Campbell, SJ
    Pav, S
    Graham, ET
    Pitner, TP
    JOURNAL OF ENZYME INHIBITION, 1997, 11 (03): : 151 - 169
  • [37] DIPEPTIDYL PEPTIDASE-IV (CD26) - EXPRESSION, STRUCTURE AND FUNCTIONS IN LYMPHOCYTES
    MARGUET, D
    DAVID, F
    VIVIER, I
    BERNARD, AM
    NAQUET, P
    PIERRES, M
    ADVANCES IN NEUROIMMUNOLOGY, 1993, 3 (03): : 209 - 215
  • [38] Molecular associations required for signalling via dipeptidyl peptidase IV (CD26)
    Fleischer, B
    Steeg, C
    Huhn, J
    vonBonin, A
    CELLULAR PEPTIDASES IN IMMUNE FUNCTIONS AND DISEASES, 1997, 421 : 117 - 125
  • [39] Prodrugs of antiviral nucleosides cleavable by dipeptidyl-peptidase-IV (CD26)
    Velazquez, Sonsoles
    Diez-Torrubia, Alberto
    Peromingo, M. Teresa
    Garcia-Aparicio, Carlos
    Balzarini, Jan
    Camarasa, Maria-Jose
    ANTIVIRAL RESEARCH, 2008, 78 (02) : A66 - A66
  • [40] Fluoroolefin containing dipeptide isosteres as inhibitors of dipeptidyl peptidase IV (CD26)
    Welch, JT
    Lin, J
    TETRAHEDRON, 1996, 52 (01) : 291 - 304